CWChaomin Wan

Chaomin Wan

*This is an algorithmically generated author record based on publicly available information.

Chaomin Wan has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Abnormal somatosensory evoked potentials in a child with motor conversion disorder: A case report

    by Tao Yu, Jiucai Ye, Yao Deng, Rong Luo, Chaomin Wan


  • Open Access

    Antibiotic Resistance of Helicobacter pylori Strains Isolated From Pediatric Patients in Southwest China

    by Juan Li, Jianjun Deng, Zhiling Wang, Hong Li, Chaomin Wan

    The number of antibiotics that are appropriate for Helicobacter pylori eradication in children is limited. Profiling regional or population-specific antibiotic resistance is essential in guiding the H. pylori eradication treatment in children. The aim of this study was to evaluate the antibiotic resistance in H. pylori strains isolated from children and adolescents in Southwest China. Gastric biopsies from 157 pediatric patients with or without previous H. pylori eradication treatment were collected for H. pylori culture. Susceptibility to amoxicillin (AML), clarithromycin (CLR), metronidazole (MTZ), levofloxacin (LEV), tetracycline (TET), furazolidone (FZD), and rifampicin (RIF) was determined by E-test or a disk diffusion assay. A total of 87 patients from three ethnic groups (Han/Tibetan/Yi) were H. pylori culture positive (55.4%). The overall resistance rates were 55.2% for CLR, 71.3% for MTZ, 60.9% for RIF, and 18.4% for LEV. No isolate was found to be resistant to AML, TET, and FZD. Among the 53 treatment-naïve pediatric patients, primary resistance rates to clarithromycin, metronidazole, levofloxacin, and rifampicin were 45.3, 73.6, 15.1, and 60.4%, respectively. Among the 34 treatment-experienced patients, secondary resistance rates to clarithromycin, metronidazole, levofloxacin, and rifampicin were 70.6, 67.6, 23.5, and 61.8%, respectively. Isolates exhibiting simultaneous resistance to clarithromycin and metronidazole were 28.3 and 52.9% among the treatment-naïve and treatment-experienced patients, respectively. In conclusion, among pediatric patients in Southwest China, resistance rates were high for clarithromycin, metronidazole, levofloxacin, and rifampicin, whereas nil resistance was found to amoxicillin, tetracycline, and furazolidone. Our data suggest that the standard clarithromycin-based triple therapy should be abandoned as empiric therapy, whereas the bismuth quadruple therapy (bismuth/PPI/amoxicillin/tetracycline) would be suitable as first-line empiric treatment regimen for this pediatric population. Tetracycline and furazolidone may be considered for treating refractory H. pylori infections in adolescent patients.


  • Open Access

    Distinguishing tuberculosis pleural effusion from parasitic pleural effusion using pleural fluid characteristics

    by Shuai Tong, Yu Zhu, Chaomin Wan

    Tuberculosis pleural effusion (TPE) and parasitic pleural effusion (PPE) present with similar clinical manifestations. We evaluated the pleural fluid features of TPE and PPE. A total of 76 patients with pleuritis, including 25 patients with TPE and 51 patients with PPE were retrospectively studied. Pleural fluid was sent for analyses of protein, cytology, cell count, acid fast bacilli (AFB) staining, Gram stain, culture, sensitivity, and adenosine dehydrogenase (ADA). The proportion of eosinophilia present in the PPE group was significantly higher than that in the TPE group (P < .001). However, the proportion of lymphocytes found in the TPE group was significantly higher than that in the PPE group (P < .001). The mean level (SD) of ADA was 46.99 ± 22.09 U/L in the TPE group and 39.08 ± 23.03 U/L in the PPE group. No difference was detected between the study groups in terms of the ADA level of the pleural fluid (P > .05). When the results of pleural fluid testing reveal marked eosinophilia and a low proportion of lymphocytes, physicians should consider a diagnosis of PPE, especially for patients who live in or have traveled to endemic areas.


  • Open Access

    Facial paralysis as a presenting symptom of infant leukemia

    by Liyuan Wang, Zhiling Wang, Chaomin Wan, Xiaotang Cai, Ge Zhang, Chunqi Lai

    Rationale: Facial paralysis as the initial clinical presentation of infant leukemia (IL) is rare, and the rate of its misdiagnosis is high. Identifying the clinical characteristics of IL with facial paralysis as the initial symptom is necessary to improve the understanding of the causes of facial paralysis and IL. Patient concerns: A 10-month-old infant had facial paralysis and recurrent fever. He was misdiagnosed as having bacterial meningitis for >2 months. Diagnoses: The infant was diagnosed as having acute monocytic leukemia (M5) with central infiltration based on examinations of the bone marrow and cerebrospinal fluid by flow cytometry. Interventions: Before the diagnosis of leukemia, the patient was given meropenem, ceftriaxone, vancomycin, and ampicillin successively for anti-infective treatment for 2 months, and dexamethasone for several days. But he gave up further treatment after confirmed diagnosis. Outcomes: Our patient discontinued treatment and discharged. From literature review, there were 6 cases (including this case) of IL with facial paralysis as the initial symptom. 80% of patients were misdiagnosis and treated with a corticosteroid in the early stage, and the mortality was 33.3%. Lessons: The clinical symptoms of IL with facial paralysis are not typical, with a high rate of misdiagnosis. When the cause of facial paralysis is unknown or the advance treatment effect is poor, tumor diseases should be considered. Corticosteroids should be carefully administered to children with facial paralysis.


  • Open Access

    Changes in prevalence and perinatal outcomes of congenital hydrocephalus among Chinese newborns: a retrospective analysis based on the hospital-based birth defects surveillance system

    by Ling Yi, Chaomin Wan, Changfei Deng, Xiaohong Li, Kui Deng, Yi Mu, Jun Zhu, Qi Li, Yanping Wang, Li Dai

    Little is known about the epidemiology of congenital hydrocephalus (CH) in China. This study aimed to depict recent changes in CH prevalence and perinatal outcomes of the affected newborns. Data were obtained from the Chinese Birth Defects Monitoring Network (CBDMN), which collects demographic information on all newborns above 28 weeks of gestation, and clinical information on neonates with congenital anomalies. CH cases delivered during 2005–2012 were analyzed. Poisson regression was used to calculate prevalence ratios (PR) and 95% confidence intervals, and linear chi-square test was used to examine time trend of CH prevalence. Five thousand two hundred forty-five isolated and 1245 associated CH cases were identified among 10,574,061 newborns, yielding the prevalence of 4.96, 1.18 and 6.14 per 10,000 births for the isolated, associated and overall hydrocephalus, respectively. The annual prevalence of CH presented a decreasing trend (from 7.52 to 5.98 per 10,000 births, P < 0.001). Higher prevalence was found in both younger (<20 years, PR: 1.81, 95% CI: 1.56–2.10) and older (≥35 years, PR: 1.48, 95% CI: 1.36–1.61) maternal-age groups in comparison with the maternal-age group of 20 to 24 years. Higher prevalence was also found in infants born to mothers resided in rural areas, male infants, and multiple births. Of non-aborted infants with congenital hydrocephalus, 38.11% were born with low birth weight, 37.53% were preterm birth, and 20.69% died within 7 days after birth. Our findings present a relatively high prevalence and poor perinatal outcomes of CH in China, which can serve as a baseline for future study.


  • Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies

    by Qian-Yun Cai, Zhong-Jie Zhou, Rong Luo, Jing Gan, Shi-Ping Li, De-Zhi Mu, Chao-Min Wan

    To review the available evidence from prospective studies on the safety and tolerability of the ketogenic diet (KD) for the treatment of refractory childhood epilepsy.


  • Open Access

    Does stroke volume variation predict fluid responsiveness in children: A systematic review and meta-analysis

    by Ling Yi, Zhongqiang Liu, Lina Qiao, Chaomin Wan, Dezhi Mu

    Stroke volume variation (SVV) is a reliable predictor of fluid responsiveness in adult patients. However, the predictive value of SVV is uncertain in pediatric patients. We performed the first systematic meta-analysis to evaluate the diagnostic value of SVV in predicting fluid responsiveness in children. PUBMED, EMBASE, and Cochrane Central Register of Controlled Trials were searched up to December 2016. Original studies assessing the diagnostic accuracy of SVV in predicting fluid responsiveness in children were considered to be eligible. A random-effects model was used to calculate pooled values of sensitivity, specificity and diagnostic odds ratio with 95% CI. The summary receiver operating characteristic curve was estimated and area under the curve was calculated. Quality of the studies was assessed with the QUADAS-2 tool. Six studies with a total of 279 fluid boluses in 224 children were included. The analysis demonstrated a pooled sensitivity of 0.68 (95% CI,0.59–0.76), pooled specificity of 0.65 (95% CI, 0.57–0.73), pooled diagnostic odds ratio of 8.24 (95% CI, 2.58–26.30), and the summary area under the summary receiver operating characteristic curve of 0.81. However, significant inter-study heterogeneity was found (pI2 = 61.3%), likely due to small sample size and diverse study characteristics. Current evidence suggests that SVV was of diagnostic value in predicting fluid responsiveness in children under mechanical ventilation. Given the high heterogeneity of published data, further studies are needed to confirm the diagnostic accuracy of SVV in predicting fluid responsiveness in pediatric patients.


    • 1 May 2017
      • Vol. 19  (5) , 596-600

    儿童慢性肝病营养状况评估方法研究进展

    by Shuai Tong, Yu Zhu, Chao-Min Wan

    营养不良普遍存在于慢性肝病患儿中,且二者相互影响。慢性肝病可以造成营养不良,而营养不良可以影响慢性肝病患儿的预后。由于慢性肝病营养状况评价的复杂性,目前对于慢性肝病患儿营养不良的诊断尚缺乏统一的标准,尽早发现肝病患者的营养不良并对其进行干预,将有助于改善慢性肝病患儿的预后。该文综述儿童慢性肝病的营养特点及慢性肝病患儿营养状况的评估方法。

    • 1 August 2016
      • Vol. 18  (8) , 713-717

    无基础疾病儿童侵袭性真菌病的临床研究

    by Wei-Ran Li, Si-Yan Deng, Min Shu, Yu Zhu, Yang Wen, Qin Guo, Qiong Liao, Chao-Min Wan

    探讨无基础疾病儿童侵袭性真菌病(IFD)的临床特点。 回顾性分析49例无基础疾病侵袭性真菌病患儿的临床资料。 无基础疾病侵袭性真菌病儿童的病原检出率为76%(37/49),其中新型隐球菌(17例,46%)、白色假丝酵母菌(10例,27%)、曲霉菌及近平滑假丝酵母菌(各3例,均占8%)为最常见的病原。真菌性肺炎最多见(17例,46%),病原以白色假丝酵母菌为主(9例,53%)。49例患儿均存在至少一项感染高危因素,主要为抗生素使用、长时间住院以及侵袭性操作。行G试验检查的24例中17例阳性(71%)。49例患儿均接受抗真菌治疗,37例(75%)治愈,3例(6%)仍在治疗中,5例(10%)死亡,4例(8%)失访。 对于无基础疾病的IFD患儿,新型隐球菌、念珠菌为其主要病原,肺部感染最为多见。长期大量使用抗生素是较突出危险因素。无基础疾病的IFD患儿对于抗真菌药物敏感,预后较好。


  • Effects of problem‐based learning in paediatric education in China: a meta‐analysis

    by Xiaolin Gao, Shuanghong Luo, Dezhi Mu, Ying Xiong, Liu Guanjian, Chaomin Wan

    Objective: To evaluate the efficiency of Problem‐Based Learning (PBL) in paediatric education.Methods: The research articles on the application of PBL to Chinese paediatric education published in from 1989 to 2014 in the Cochrane library, PubMed/MEDLINE, EBSCO (Elton B. Stephens Company Database), OVID (Ovid Technologies Database), Web of Science, CNKI (China National Knowledge Infrastructure Database), VIP (Wei Pu Database), WF (WanFang Database) and other databases were retrieved by two independent evaluators according to the inclusion and exclusion criteria. The heterogeneity of the retrieved data was analysed and a meta‐analysis was performed using the RevMan 5.3 software.Results: The articles were initially retrieved, and 11 randomized controlled trials (RCTs) were included for the meta‐analysis. The PBL group was significantly superior to the Lecture‐Based Learning (LBL) group for the paediatrics theoretical test score, case analysis score and overall student satisfaction, and the differences were statistically significant (P < 0.05).Conclusions: PBL is superior to LBL method for Chinese paediatric education.